Cizzle Bio, Inc., a biotechnology company pioneering innovative biomarker blood tests for early detection of lung and gastric ...

The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined the pros and cons of biomarker-based ...

Indian American biomedical researcher has reported novel biomarkers for colorectal, bladder, prostate, stomach and pancreatic ...

Geneticist Nilabja Sikdar in Calcutta, with collaborators in Jadavpur University, Israel and the US, has found that patients ...

Got a sore throat and the sniffles? The recent rise of rapid at-home tests has made it easier to find out if you have a ...

Leaders at the Ellison Medical Institute (EMI) have outlined a bold vision for a nationwide enterprise architecture that ...

Uterine cancer incidence and mortality rates are projected to increase significantly through 2050, according to a study ...

It is called HUNK (acronym of Hormonally Upregulated Neu-associated Kinase) and it is a new biomarker for gastric cancer: it ...

About 69,000 new cases and nearly 14,000 deaths are expected this year, according to the American Cancer Society.

STAMPEDE otherwise follows a line of randomized trials (e.g., MAST, TAXOMET, IMPROVE) that have failed to prove cancer ...

Corticosteroids are commonly prescribed to alleviate cancer-related symptoms in patients with non-small cell lung cancer, ...